Financial Performance - The company's operating revenue for Q1 2023 was CNY 2,484,717,292.35, representing a year-on-year increase of 12.20%[4] - The net profit attributable to shareholders for the same period was CNY 30,336,536.05, showing a decrease of 19.64% compared to the previous year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 25,056,650.50, down 24.15% year-on-year[4] - In Q1 2023, the company reported a net profit of CNY 10,203,203.30, compared to CNY 29,891,453.24 in Q1 2022, indicating a decrease in profitability[29] - The company reported a total profit of CNY 10,632,619.97 in Q1 2023, down from CNY 24,706,285.65 in Q1 2022, indicating a decline of about 56.9%[29] - Operating profit for Q1 2023 was 35,111,365.82, down from 55,884,956.99 in Q1 2022, marking a decrease of around 37%[18] - The company reported a total comprehensive income of 36,036,634.97, down from 55,323,132.60 in the previous year, indicating a decline of about 35%[19] Cash Flow and Liquidity - The net cash flow from operating activities was negative at CNY -109,711,564.64, indicating a significant cash outflow[4] - The operating cash flow for Q1 2023 was CNY 54,705,527.55, a significant improvement from a negative cash flow of CNY -346,921,935.18 in Q1 2022[30] - The company experienced a net cash increase of CNY 45,211,817.39 in Q1 2023, contrasting with a decrease of CNY -401,833,696.51 in the same period last year[31] - The company incurred research and development expenses of 58,139,950.03, compared to 51,465,378.39 in Q1 2022, reflecting an increase of approximately 13%[18] - The company raised 130,650,897.51 in cash from financing activities, compared to 45,000,000.00 in Q1 2022, showing a significant increase of about 190%[23] Assets and Liabilities - The total assets at the end of the reporting period were CNY 7,629,404,135.54, a slight increase of 0.46% from the end of the previous year[5] - Total liabilities as of March 31, 2023, were ¥4,880,931,621.61, slightly down from ¥4,882,061,853.91 at the end of 2022[15] - The total assets as of March 31, 2023, were 5,695,984,240.59 RMB, a decrease from 5,922,614,414.08 RMB at the end of 2022[26] - Total liabilities decreased to 2,993,823,451.18 RMB as of March 31, 2023, compared to 3,230,703,606.97 RMB at the end of 2022[27] - The company's total liabilities decreased from CNY 1,145,815,815.06 in Q1 2022 to CNY 619,504.66 in Q1 2023, indicating a significant reduction in debt levels[29] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 46,063[9] - The top three shareholders held a combined 43.75% of the total shares, with the largest shareholder owning 23.03%[10] - The company completed the repurchase and cancellation of 150,900 restricted stocks, reducing the total share capital to 798,014,769 shares[5] Research and Development - The company plans to continue focusing on R&D and market expansion strategies to enhance future growth prospects[28] - Research and development expenses increased to 40,647,294.01 RMB in Q1 2023, up from 38,480,471.35 RMB in Q1 2022, reflecting a focus on innovation[28]
澳柯玛(600336) - 2023 Q1 - 季度财报